As of 2025-07-14, the Intrinsic Value of Metabolic Explorer SA (METEX.PA) is 5,348.97 EUR. This METEX.PA valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 0.12 EUR, the upside of Metabolic Explorer SA is 4,405,972.30%.
The range of the Intrinsic Value is 2,685.59 - 8,064.01 EUR
Based on its market price of 0.12 EUR and our intrinsic valuation, Metabolic Explorer SA (METEX.PA) is undervalued by 4,405,972.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (84,064.35) - (5,501.18) | (10,115.10) | -8332144.6% |
| DCF (Growth 10y) | (1,767.04) - (14,360.83) | (2,531.21) | -2085113.0% |
| DCF (EBITDA 5y) | 2,685.59 - 8,064.01 | 5,348.97 | 4405972.3% |
| DCF (EBITDA 10y) | 3,540.23 - 12,216.97 | 7,543.42 | 6213593.2% |
| Fair Value | -24.20 - -24.20 | -24.20 | -20,037.91% |
| P/E | (12.86) - (12.08) | (12.59) | -10467.7% |
| EV/EBITDA | (10.93) - 943.46 | 380.00 | 312918.8% |
| EPV | (395.57) - (704.13) | (549.85) | -453021.6% |
| DDM - Stable | (7.83) - (84.69) | (46.26) | -38206.6% |
| DDM - Multi | (1.05) - (9.87) | (1.97) | -1723.8% |
| Market Cap (mil) | 6.18 |
| Beta | 3.20 |
| Outstanding shares (mil) | 50.92 |
| Enterprise Value (mil) | 64.08 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.18% |
| Cost of Debt | 5.50% |
| WACC | 5.47% |